Beijing Nuokangda Pharmaceutical Technology

Beijing Nuokangda Pharmaceutical Technology specializes in the research and development of innovative drug preparations and advanced polymer-based injectable biomaterials. The company has a dual business focus on pharmaceuticals—including preclinical assets targeting diabetes mellitus, xerophthalmia, pain, and non-small cell lung cancer—and medical aesthetic products such as polycaprolactone microsphere facial fillers. It collaborates with partners like Sichuan Sinco on R&D projects involving novel filler materials and delivery devices ("secret needle" technology). Several clinical trials are registered under its name or with partners.